breast cancer
Conditions
Interventions
MLD+Instrument-assisted soft tissue mobilization group:Instrument-assisted soft tissue mobilization
MLD group:Bare hand lymphatic drainage
Sponsors
The Fifth Affiliated Hospital Sun Yat-sen University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1: Pathologically diagnosed breast cancer, according to the international TNM stage (stage I-III) concurrent breast cancer surgery, and according to the chronic pain standards of the International Association for the Study of Pain (IASP), the determination of PMPS in this study should meet the different degrees of pain in the breast or chest wall, armpit and inner forearm on the same side of the operation after surgery, the VAS score is = 1, and the pain time exceeds the normal tissue healing time after breast surgery (3 months) 2: Conscious mind, no language communication disorder, no mental disorders, able to understand the content of the scale and cooperate with treatment 3: No serious organ diseases and no serious complications after surgery 4: Those who can complete 4 weeks (3 times a week) of treatment and 2 weeks of follow-up after treatment, and do not use painkillers during treatment. 5. Patients who agree to participate in the research of the project and sign the consent form 5: A female patient > 18 years of age with good cognitive and behavioral abilities 6: Patients participate voluntarily, agree and sign informed consent.
Exclusion criteria
Exclusion criteria: 1: Those who have chronic pain in the observation area before surgery, and those who have previous neuromuscular system diseases 2: Patients with serious organ diseases in the past, such as cardiovascular, brain, kidney and other medical diseases, or primary severe diseases such as hematopoietic system and diabetes 3: Patients with serious complications such as large-scale surgical mouth infection, flap necrosis and venous embolism after surgery 4: Contraindications related to extracorporeal shock wave therapy, such as deep vein thrombosis, primary lymphatic system diseases, coagulation disorders, limb trauma or ulcers and other skin diseases, bleeding tendency, etc. 5: Those with cognitive impairment or physical impairment, unable to understand the content of the scale, unable to evaluate the efficacy, unwilling to participate in the trial or unable to actively cooperate 6: Unwilling to participate in the experiment or unable to actively cooperate 7: Women who are pregnant or trying to get pregnant 8: Previous history of mental illness or dementia or poor compliance 9: Is participating in other similar related clinical investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SF-12; | — |
Secondary
| Measure | Time frame |
|---|---|
| range of motion;Visual Analogue Scale; | — |
Countries
China
Contacts
Public ContactZhang Peng
The Fifth Affiliated Hospital Sun Yat-sen University
Outcome results
None listed